Deep learning–driven multi-omics analysis: enhancing cancer diagnostics and therapeutics
Briefings in Bioinformatics · 02.07.2025 · 26 (4)
DOI: 10.1093/bib/bbaf440 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 28.08.2025. Verfasst von Jiayang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Hospital of Jilin University, 218 zigiang Street, Changchun, 130041, People's Republic of China. Hauptthemen laut MEDLINE: Deep Learning, Neoplasms, Genomics, Computational Biology. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jilin Provincial Scientific and Technological Development Program.
Abstract (Originalsprache)
Artificial intelligence (AI) excels at efficiently processing large volumes of data and extracting valuable insights. Deep Learning (DL), a subfield of AI, utilizes multi-layer neural network algorithms to analyze various types of data, mimicking the neural network architecture of the human brain. One of the most prominent features of DL is its end-to-end learning mechanism, which excels at automatic feature extraction and pattern recognition in data. As multi-omics technologies rapidly evolve, the volume of omics data from cancer samples has surged, presenting a significant challenge in managing this vast amount of information. Due to its strong data processing capabilities, DL is increasingly applied across a range of cancer research areas, such as early detection and screening, diagnosis, molecular subtype classification, discovery of biomarkers, and predicting patient prognosis and treatment responses. DL integrates high-dimensional data from fields such as genomics, epigenomics, transcriptomics, proteomics, radiomics, and single-cell omics, enhancing our understanding of cancer development and advancing personalized treatment approaches. This paper reviews various DL models and their roles in analyzing complex data patterns, providing a review of DL applications in cancer multi-omics analysis research and emphasizing its potential in early detection, diagnosis, classification, and prognosis prediction. As DL models are introduced continuously, we expect their application in cancer research to become more extensive, thus propelling the advancement of cancer medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Second Hospital of Jilin University, 218 zigiang Street, Changchun, 130041, People's Republic of China.
- NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, 1163 Xinmin Street, Changchun, 130021, People's Republic of China.
ORCID-Profile: Zhicheng Wang
Förderung
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Zhang, J., Che, Y., Liu, R., Wang, Z., & Liu, W. (2025). Deep learning–driven multi-omics analysis: enhancing cancer diagnostics and therapeutics. Briefings in Bioinformatics, 26(4). https://doi.org/10.1093/bib/bbaf440
Vancouver
Zhang J, Che Y, Liu R, Wang Z, Liu W. Deep learning–driven multi-omics analysis: enhancing cancer diagnostics and therapeutics. Briefings in Bioinformatics. 2025;26(4). doi:10.1093/bib/bbaf440
BibTeX
@article{Zhang2025,
author = {Zhang, Jiayang and Che, Yilin and Liu, Rongrong and Wang, Zhicheng and Liu, Weiwu},
title = {Deep learning–driven multi-omics analysis: enhancing cancer diagnostics and therapeutics},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {4},
doi = {10.1093/bib/bbaf440}
}
EUVIMED